SCHEMBL8008689

SCHEMBL8008689

CCOc1ccccc1NC=C1C(=O)N(c2ccc(S(=O)(=O)N(CC)CC)cc2)N=C1C(CC)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.40
ALDH1A1 P00352 6/20 0.39
GAA P10253 1/20 0.38
KMT2A Q03164 5/20 0.38
HTT P42858 4/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 1/20 0.38
PTGS2 P35354 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 3/20 0.36
RAB9A P51151 3/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
SHMT2 P34897 1/20 0.35
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8009329 0.89 SHMT2 (0.37) ALDH1A1KMT2AHTTMAPTRAB9A
SCHEMBL6947834 0.85 THRB (0.44) THRBALDH1A1GAAKMT2AHTT
SCHEMBL6947838 0.85 THRB (0.44) THRBALDH1A1GAAKMT2AHTT
SCHEMBL6949542 0.84 PTGS2 (0.47) THRBALDH1A1GAAKMT2AHTT
SCHEMBL6949544 0.84 PTGS2 (0.47) THRBALDH1A1GAAKMT2AHTT
SCHEMBL8008686 0.82 THRB (0.43) THRBALDH1A1GAAKMT2AHTT
SCHEMBL8008685 0.82 THRB (0.43) THRBALDH1A1GAAKMT2AHTT
SCHEMBL6953331 0.82 ALDH1A1 (0.47) THRBALDH1A1GAAKMT2AHTT
SCHEMBL6953328 0.82 ALDH1A1 (0.47) THRBALDH1A1GAAKMT2AHTT
SCHEMBL8428063 0.80 PTGS2 (0.45) THRBALDH1A1GAAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed